AXSOME THERAPEUTICS, INC. Payments of Loan Costs
AXSOME THERAPEUTICS, INC. (AXSM) reported Payments of Loan Costs of $121.24 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfLoanCosts · last filed 2017-03-07
- AXSOME THERAPEUTICS, INC. payments of loan costs for the quarter ending 2015-09-30 was -$33.47K.
- AXSOME THERAPEUTICS, INC. payments of loan costs for the quarter ending 2015-06-30 was $141.43K.
- AXSOME THERAPEUTICS, INC. payments of loan costs for the quarter ending 2015-03-31 was $13.28K.
- AXSOME THERAPEUTICS, INC. payments of loan costs for fiscal 2014 was $42.62K.
| Period end | Payments of Loan Costs 3 month | Payments of Loan Costs 6 month | Payments of Loan Costs 9 month | Payments of Loan Costs 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$33.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $107.96K derived: sum of 2 quarters · filed 2016-11-14 | $121.24K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $141.43K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | $154.70K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $13.28K 10-Q/A · filed 2016-08-09 | |||
| 2014-12-31 | $42.62K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |